News

Panel of TB experts releases report calling for the prioritization of tuberculosis R&D

On June 9th, the Center for Strategic and International Studies (CSIS) released six policy reports detailing the domestic and global health burden of tuberculosis and recommendations for the United States government to combat the disease. The policy reports were the culmination of major findings from the CSIS Global Health Policy Center (GHPC), a working group composed of leading tuberculosis experts. In summary, the GHPC overview report titled “Strengthening the U.S. Approach to Tuberculosis Research and Development” called for the prioritization of TB R&D by the provision of more resources for research and innovation. To read the overview report click here. The six major reports released by the CSIS Global Health Policy Center can be found here.

Related Links

A Strategic Approach to Global Tuberculosis

Tuberculosis R&D must be U.S. diplomatic priority, say global health leaders

Tuberculosis panel: U.S. effort must focus, prioritize, coordinate

Additional Links

Center for Strategic and International Studies

CSIS Global Health Policy Center

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...